Radu, A., Pichon, Ch., Antoine, M., Allorry, Y., Couvelard, A., Fromont, G., Hai, M.T.V. and Ghinea, N. (2010) Expression of Follicle-Stimulating Hormone Receptor in Tumor Blood Vessels. The New England Journal of Medicine, 363, 1621-1630.
http://dx.doi.org/10.1056/NEJMoa1001283

has been cited by the following article:

• TITLE: Molecular Marker of Tumours

  AUTHORS: Marian Surma

  KEYWORDS: Cancer, Molecular Marker, Protein Markers

  JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.10, September 22, 2016

  ABSTRACT: Molecular structure of the marker of tumour is determined by magneto-optical analysis of blood serum. The marker is the laevorotatory enantiomer of alanine. The cancer status of a subject is described by the number of molecules of the laevorotatory alanine enantiomer (-)ρ and the effectiveness of therapy is measured by the number of molecules of the dextrorotatory alanine enantiomer (+)ρ. The values of (-)ρ and (+)ρ are determined separately for the patient before and after therapy.